GUIDE
Peptides for Sexual Health
Separates FDA-approved bremelanotide context from unapproved melanocortin compounds.
What to ask your clinician
Which claims are label-based, which are investigational, and which safety warnings apply to your situation?
Evidence distinction
Human randomized data, observational reports, animal studies, and marketing claims are ranked separately.
Regulatory distinction
Approved medications, supplements, cosmetic ingredients, compounded products, and RUO compounds are not equivalent.
Plain-English guide
Separates FDA-approved bremelanotide context from unapproved melanocortin compounds.
Use this guide as a map, not a recommendation list. Start by separating approved product labels from research-only, supplement, cosmetic, and marketing claims. Then compare evidence grade, route, safety score, and source quality before reading individual peptide profiles.
For any peptide with an approved product context, the official label is the primary source for indications, warnings, contraindications, and adverse reactions. For investigational or research-use-only entries, treat the profile as a source-review starting point rather than proof of safety or effectiveness.
Ranked entries
AOD-9604
Metabolic and body-composition research
Apelin
Cardiovascular and metabolic pathway research
BPC-157
Tissue repair and gut pathway research
Bremelanotide
FDA-approved product context for acquired, generalized hypoactive sexual desire disorder in premenopausal women
Collagen peptides
Skin, joint, and nutrition supplement context
Kisspeptin
Reproductive endocrinology and GnRH-axis research
KPV
Inflammatory and gut pathway research
Melanotan II
Pigmentation and melanocortin pathway research
MOTS-c
Metabolic and aging-pathway research
Oxyntomodulin
Metabolic and appetite-regulation research
Peptide YY
Appetite and gut-brain axis research